Search alternatives:
larger decrease » marked decrease (Expand Search)
process mean » process real (Expand Search), processed meat (Expand Search), process led (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 101 - 120 results of 1,154 for search '(( third ((larger decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( process mean decrease ))', query time: 0.56s Refine Results
  1. 101
    Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points.

    Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

    Published 2024
    Save to List
    Saved in:
  2. 102
    Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points.

    Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

    Published 2024
    Save to List
    Saved in:
  3. 103
    Downregulation of <i>TcPiezo1</i> expression decreases Ca<sup>2+</sup> entry in <i>T. cruzi.</i>

    Downregulation of <i>TcPiezo1</i> expression decreases Ca<sup>2+</sup> entry in <i>T. cruzi.</i> by Guozhong Huang (673424)

    Published 2025
    Save to List
    Saved in:
  4. 104
    Change<sup>a</sup> in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score.

    Change<sup>a</sup> in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

    Published 2024
    Save to List
    Saved in:
  5. 105
    Change<sup>a</sup> in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score.

    Change<sup>a</sup> in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

    Published 2024
    Save to List
    Saved in:
  6. 106
    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  7. 107
    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  8. 108
    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  9. 109
    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  10. 110
    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  11. 111
    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  12. 112
    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  13. 113
    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  14. 114
    Decreased lung pyroptosis and infiltrating neutrophil necroptosis in <i>Casp1</i><sup>-/-</sup> mice during pulmonary <i>E. coli</i> infection.

    Decreased lung pyroptosis and infiltrating neutrophil necroptosis in <i>Casp1</i><sup>-/-</sup> mice during pulmonary <i>E. coli</i> infection. by Qinyu Luo (13000956)

    Published 2025
    Save to List
    Saved in:
  15. 115
    Change<sup>a</sup> in years of age at school entry according to a one-unit change in the initial value of the height-for-age z-score.

    Change<sup>a</sup> in years of age at school entry according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

    Published 2024
    Save to List
    Saved in:
  16. 116
    Change<sup>a</sup> in incidence of repetition [95% confidence interval].

    Change<sup>a</sup> in incidence of repetition [95% confidence interval]. by Rabi Joël Gansaonré (20416803)

    Published 2024
    Save to List
    Saved in:
  17. 117
    PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predation.

    PRCC values (with <i>p</i>-values in parentheses) for the median final population size and difference in mean MSI at the final time, without weevil predation and with weevil predat... by Alexandra M. Campbell (3284094)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 118
    Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) and with weevils present for <i>T</i><sub><i>p</i></sub> years (right); each color represents a single experiment (100 simulations of 1 parameter set).

    Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 119
    Table 1_Higher oxidative balance score is associated with a decreased risk of infertility: an analysis of NHANES 2013–2020.docx

    Table 1_Higher oxidative balance score is associated with a decreased risk of infertility: an analysis of NHANES 2013–2020.docx by Mingjun Ma (11518765)

    Published 2025
    Save to List
    Saved in:
  20. 120
    Change<sup>a</sup> in age at school entry [95% confidence interval].

    Change<sup>a</sup> in age at school entry [95% confidence interval]. by Rabi Joël Gansaonré (20416803)

    Published 2024
    Save to List
    Saved in:

Search Tools: